Electrical Muscle Stimulation Effect Versus Myofascial Release on Quality of Life in Female Fibromyalgia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-55
SponsorCairo University

About this trial

the study was done to investigate the effect of Electrical Muscle Stimulation as muscle strengthening versus the effect of myofascial releasing on quality of life in female fibromyalgia patients while following Mediterranean diet.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Sixty females have diagnosed suffering from fibromyalgia syndrome.

Their ages will be ranged from 45 to 55 years old.

Their body mass index will be ranged from 25 to 34 ( overweight and obese type 1)

They have willingness to participate in this study.

Disqualifiers

Peripheral vascular diseases.

Drug abuse.

Smokers.

Chest disease. ( either obstructive or restrictive ).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Electrical myostimulation

    Device

    Electrical myostimulation in form of suit as in fig. Blue lines demonstrate areas of electrodes inside suit. twenty females will receive EMS session per week ( 20mins / week ) and following healthy diet for 6 weeks . 20 min = 1 min warm up, 6min upper body training, 6min lower body training, 6min core training, 1 min cooling down.

  • Electronic cupping

    Device

    Twenty females will undergo two weekly myofascial release sessions and a healthy diet for six weeks, using electronic cupping to ensure equal pressure on tender points.

  • healthy diet

    Other intervention

    The MedDiet diet focuses on high fat intake, primarily from extra-virgin olive oil, in vegetable dishes, and a high consumption of low-glycemic index carbohydrates like wholegrain cereals, legumes, nuts, fruits, and vegetables. Moderate to high fish consumption is also encouraged, with moderate to small amounts of poultry and dairy products. Red meat and meat products are limited or avoided.

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Electrical MyostimulationExperimental treatment 2 interventions
Group B: Myofascial ReleaseActive comparator 2 interventions
Group C: Healthy dietActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Assessment of change of body mass index

to measure body weight and height to calculate BMI for characterizing the sample.

Time frame
at baseline and after 6 weeks
2

Assessment of change of pressure pain threshold using algometry

Algometry is a useful tool for assessing central allodynia and hyperalgesia in FM and other pain conditions. It can provide insights into psychological factors influencing pain experience, new dynamic pain indicators, and neuroimaging techniques.

Time frame
at baseline and after 6 weeks

Secondary outcomes

1

assessment of fibromyalgia using Fibromyalgia Impact Questionnaire

The FIQ-A measures physical function, work, and well-being, including pain, fatigue, stiffness, anxiety, and depression. The Arabic version has acceptable reliability and validity criteria, suitable for clinical practice and research in the Arabic speaking population.

Time frame
at baseline and after 6 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: